View Older Stories View More Recent Stories
-
H.C. Wainwright Reiterates Buy Rating on AC Immune SA (ACIU)
-
H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE)
-
H.C. Wainwright Reiterates Buy Rating on Akebia Therapeutics (AKBA)
-
Viking Therapeutic (VKTX) Reiterated at Overweight by Cantor Fitzgerald
-
Jones Trading Starts FTAI Infrastructure (FIP) at Buy
-
Marriott and Coca-Cola strike global beverage supply agreement
-
707 Cayman Holdings board approves AI and blockchain platform study
-
INmune Bio files CORDStrom patent in U.S. after favorable PCT opinion
-
Vertical Research Partners Starts Honeywell Aerospace Inc (HONA) at Hold
-
iBio reports preclinical data on IBIO-610 Activin E antibody in obese NHPs
-
FAA certifies Gogo Galileo HDX for Gulfstream G650 aircraft
-
Seer wins EU patent case, ITC probes Nanomics over IP claims
-
Guardian Metal Resources (GMET:LN) PT Lowered to GBP3.25 at BMO Capital
-
National Grid Ventures buys 35% stake in Joulent for $1.75bn
-
Bausch + Lomb survey links dry eye treatment to emotional wellbeing
-
Samsung Bioepis relaunches eye disease biosimilar with Harrow in the US
-
Silvercorp Metals Inc. (SVM:CN) (SVM) PT Lowered to Cdn$20 at BMO Capital
-
MBA Mortgage Applications 0% vs 1% Prior
-
H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)
-
Fox River Issues Shares Pursuant to Exploration Agreement in Connection with Impending Arrangement
-
ZEO ScientifiX to Host Live Educational Webinar for Healthcare Professionals Exploring the Southeast Regenerative Medicine Revolution
-
Germany's ePA Rollout Puts Europe's Health-Data Supply Chain to the Test, Black Book Provider Pulse Finds
-
Design Therapeutics (DSGN) Reiterated at Overweight by Cantor Fitzgerald
-
H.C. Wainwright Reiterates Buy Rating on Pacira Pharmaceuticals (PCRX)
-
H.C. Wainwright Reiterates Buy Rating on Septerna Inc (SEPN)
-
H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
-
Primaris REIT (PMZ-U:CN) PT Raised to Cdn$25 at BMO Capital
-
Cantor Fitzgerald Starts Forward Industries (FWDI) at Overweight
-
Tesla registrations in Spain climb 5.6% in June
-
Brightstar Lottery extends Sony Pictures Ghostbusters licensing deal
-
RPM International (RPM) Declares $0.54 Quarterly Dividend; 1.9% Yield
-
Septerna Inc (SEPN) PT Lowered to $45 at Guggenheim
-
Ecora Resources PLC Announces Update on the Phalaborwa Rare Earths Project DFS
-
Strategy (MSTR) PT Lowered to $130 at Canaccord
-
Hillman Solutions Corp. (HLMN) PT Lowered to $13 at Canaccord
-
Citi Upgrades Lockheed Martin (LMT) to Buy
-
Helus Pharma (HELP) PT Lowered to $42 at Canaccord
-
Karman Space & Defense (KRMN) Added to Citi 90-Day Upside Catalyst Watch List
-
ConnectOne Bancorp (CNOB) Removed from Raymond James Analyst Current Favorites list
-
Ladenburg Thalmann Assumes Compass Therapeutics (CMPX) at Buy
-
MSC Industrial (MSM) Tops Q3 EPS by 17c, Beats on Revenue
-
UN scientific panel warns of AI risks in first global report
-
Cameco's Cigar Lake mine halts output on mill acid plant issue
-
Dynatrace adds two directors after Starboard engagement
-
MSC Industrial Supply Co. Reports Fiscal 2026 Third Quarter Results
-
Baird Reiterates Outperform Rating on Rubrik (RBRK), 'extending our Bullish Fresh Pick on RBRK'
-
Baird Reiterates Outperform Rating on Nike (NKE)
-
BofA says markets misprice EM monetary cycles
-
Wells Fargo Lists 8 Tactical Ideas for Q3 2026
-
BYD reports 5.5% sales increase in June on export strength
